Zacks Investment Research on MSN
UiPath, Inc. (PATH) is attracting investor attention: Here is what you should know
UiPath (PATH) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...
PATH heads into Q4 earnings with revenues seen rising 9.7%, but weak stock momentum and neutral earnings signals leave investors weighing a hold stance.
UiPath (PATH) delivered earnings and revenue surprises of +20.00% and +3.50%, respectively, for the quarter ended January 2026. Do the numbers hold clues to what lies ahead for the stock?
UiPath (NYSE:PATH) shares sank 15.85% to $9.96 on Thursday, hitting a record low after the company's fiscal 2026 revenue forecast fell short of expectations. The automation software provider expects ...
Zacks Investment Research on MSN
UiPath (PATH) gains as market dips: What you should know
UiPath (PATH) closed at $11.86 in the latest trading session, marking a +2.68% move from the prior day. This move outpaced the S&P 500's daily loss of 1.33%. Elsewhere, the Dow saw a downswing of 0.95 ...
UiPath Inc. shares were on track for their worst daily drop on record after the automation-software company’s latest earnings marked a twist on the industry’s well-established doldrums. Software ...
UiPath launches AI-based Medical Record Summarization tool, reducing processing time from 45 minutes to minutes. Powered by Google Cloud, the agent improves accuracy, saves 40 minutes per referral, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results